PubRank

L Allegra

Author PubWeight™ 74.14‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 A possible association of Chlamydia pneumoniae infection and acute myocardial infarction in patients younger than 65 years of age. Chest 1997 2.11
2 Trial of roxithromycin in subjects with asthma and serological evidence of infection with Chlamydia pneumoniae. Am J Respir Crit Care Med 2001 1.79
3 Chlamydia pneumoniae and chronic bronchitis: association with severity and bacterial clearance following treatment. Thorax 2002 1.79
4 Chlamydia pneumoniae: crossing the barriers? Eur Respir J 2004 1.70
5 Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996 1.68
6 Prostaglandin E(2) inhibits fibroblast chemotaxis. Am J Physiol Lung Cell Mol Physiol 2001 1.55
7 Chlamydia pneumoniae detection in atherosclerotic plaques in Italy. J Infect Dis 2000 1.43
8 Adenosine 5'-monophosphate increases levels of leukotrienes in breath condensate in asthma. Respir Med 2004 1.43
9 Chlamydia pneumoniae infection in acute exacerbations of COPD. Eur Respir J 1993 1.36
10 Role of Mycoplasma pneumoniae and Chlamydia pneumoniae in children with community-acquired lower respiratory tract infections. Clin Infect Dis 2001 1.32
11 Chlamydia pneumoniae DNA detection in peripheral blood mononuclear cells is predictive of vascular infection. J Infect Dis 1999 1.30
12 Importance of acute Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with wheezing. Eur Respir J 2000 1.30
13 T-lymphocytes with gamma delta+ V delta 2+ antigen receptors are present in increased proportions in a fraction of patients with tuberculosis or with sarcoidosis. Am Rev Respir Dis 1993 1.28
14 Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm Pharmacol Ther 2006 1.25
15 Cellular and biochemical characteristics of bronchoalveolar lavage fluid in symptomatic nonallergic asthma. J Allergy Clin Immunol 1991 1.20
16 Blood gas changes during and after nonspecific airway challenge in asthmatic and normal subjects. J Appl Physiol (1985) 1989 1.10
17 Serological evidence of infection with Chlamydia pneumoniae is related to the severity of asthma. Eur Respir J 2000 1.03
18 Clinical, functional and pathogenetic aspects of bronchial reactivity to prostaglandins F2alpha, E1, and E2. Adv Prostaglandin Thromboxane Res 1976 1.03
19 Aspects of bronchial reactivity to prostaglandins and aspirin in asthmatic patients. Respiration 1977 1.02
20 Specific binding of endothelin on human bronchial smooth muscle cells in culture and secretion of endothelin-like material from bronchial epithelial cells. Am J Respir Cell Mol Biol 1990 1.02
21 Mycoplasma pneumoniae and Chlamydia pneumoniae infections in children with pneumonia. Mowgli Study Group. Eur Respir J 2001 1.01
22 Changes in exhaled carbon monoxide and nitric oxide levels following allergen challenge in patients with asthma. Eur Respir J 1999 1.01
23 Human ciliated bronchial epithelial cells: expression of the HLA-DR antigens and of the HLA-DR alpha gene, modulation of the HLA-DR antigens by gamma-interferon and antigen-presenting function in the mixed leukocyte reaction. Am J Respir Cell Mol Biol 1990 1.00
24 Demonstration of viable Chlamydia pneumoniae in atherosclerotic plaques of carotid arteries by reverse transcriptase polymerase chain reaction. Ann Vasc Surg 1999 0.99
25 Simple and precise method for counting ciliary beats directly from the TV monitor screen. J Pharmacol Methods 1986 0.97
26 Inhaled porcine pancreatic elastase causes bronchoconstriction via a bradykinin-mediated mechanism. J Appl Physiol (1985) 2000 0.93
27 Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res 2005 0.92
28 Short-term supplementation therapy does not affect elastin degradation in severe alpha(1)-antitrypsin deficiency. The American-Italian AATD Study Group. Am J Respir Crit Care Med 2000 0.92
29 Bronchial epithelial cells exposed to isocyanates potentiate activation and proliferation of T-cells. Am J Physiol 1990 0.91
30 Two family outbreaks of Chlamydia pneumoniae infection. Eur Respir J 1994 0.91
31 Non-specific broncho-reactivity obtained with an ultrasonic aerosol of distilled water. Eur J Respir Dis Suppl 1980 0.91
32 Diagnostic labels applied to model case histories of chronic airflow obstruction. Responses to a questionnaire in 11 North American and Western European countries. Eur Respir J 1989 0.89
33 Lung function in beta-thalassemia patients: a longitudinal study. Acta Haematol 2006 0.89
34 Severe community-acquired pneumonia: a possible role for Chlamydia pneumoniae. Respiration 1996 0.88
35 Chlamydia pneumoniae seroprevalence in immunocompetent and immunocompromised populations in Milan. Thorax 1993 0.88
36 Bacterial adherence in smokers and non-smokers. Pharmacol Res 1997 0.87
37 Chlamydia pneumoniae and Mycoplasma pneumoniae. Semin Respir Crit Care Med 2005 0.87
38 Influence of surfactant on mucociliary transport. Eur J Respir Dis Suppl 1985 0.85
39 Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness. Eur Rev Med Pharmacol Sci 2005 0.84
40 No evidence for the presence of Helicobacter pylori in atherosclerotic plaques in abdominal aortic aneurysm specimens. Atherosclerosis 1996 0.84
41 Use of antimicrobial agents for community-acquired lower respiratory tract infections in hospitalised children. Eur J Clin Microbiol Infect Dis 2001 0.84
42 Chlamydia pneumoniae eradication from carotid plaques. Results of an open, randomised treatment study. Eur J Vasc Endovasc Surg 1999 0.84
43 Azithromycin and lower respiratory tract infections. Expert Opin Pharmacother 2005 0.84
44 Nedocromil sodium prevents the release of 15-hydroxyeicosatetraenoic acid from human bronchial epithelial cells exposed to toluene diisocyanate in vitro. Int Arch Allergy Appl Immunol 1990 0.83
45 Long-lasting effects on rheology and clearance of bronchial mucus after short-term administration of high doses of carbocysteine-lysine to patients with chronic bronchitis. Respiration 1990 0.83
46 Atypical pathogens and asthma: can they influence the natural history of the disease? Monaldi Arch Chest Dis 2001 0.83
47 Experimental pulmonary calcification. Exp Med Surg 1965 0.83
48 Comparison of the bronchodilating effect of salmeterol and zafirlukast in combination with that of their use as single treatments in asthma and chronic obstructive pulmonary disease. Respiration 2001 0.82
49 Importance of drug delivery system in steroid aerosol therapy via nebulizer. Pulm Pharmacol Ther 2002 0.82
50 Lung function improvement in smokers suffering from COPD with zafirlukast, a CysLT(1)-receptor antagonist. Pulm Pharmacol Ther 2000 0.82
51 Bronchial asthma and airway hyperresponsiveness at high altitude. Respiration 1997 0.82
52 An MRI study of Chlamydia pneumoniae infection in Italian multiple sclerosis patients. Mult Scler 2003 0.81
53 Effects of ultrasonically nebulized distilled water on respiratory resistance and breathing pattern in normals and asthmatics. Bull Eur Physiopathol Respir 1984 0.81
54 Eicosanoid release from human bronchial epithelial cells upon exposure to toluene diisocyanate in vitro. J Cell Physiol 1990 0.80
55 Standards of care and clinical predictors in patients hospitalised for a COPD exacerbation--the Italian SOS (Stratification Observational Study). Monaldi Arch Chest Dis 2009 0.80
56 Beta-thalassemia and pulmonary function. Haematologica 1999 0.79
57 Advances in the research and development of chemotherapeutic agents for respiratory tract bacterial infections. Pulm Pharmacol Ther 2001 0.79
58 Pharmacokinetic behavior of S-carboxymethylcysteine-Lys in patients with chronic bronchitis. Clin Ther 1982 0.78
59 Influence and use of the employ of disodium cromoglycate "DSCG" on circadian rhythms in pulmonary mechanics. Rev Inst Hyg Mines (Hasselt) 1973 0.78
60 Classification of respiratory functional impairment in chronic obstructive pulmonary disease. Respiration 1984 0.77
61 Pollutant-induced airway abnormalities. Eur J Respir Dis Suppl 1986 0.77
62 Clinical efficacy of a vaccine-immunostimulant combination in the prevention of influenza in patients with chronic obstructive pulmonary disease and chronic asthma. J Chemother 1997 0.77
63 Ambroxol inhibits airway hyperresponsiveness induced by ozone in dogs. Respiration 1989 0.77
64 Altered surfactant synthesis and function in rats with diet-induced hyperlipidemia. Metabolism 1980 0.77
65 Duration of mucociliary dysfunction following antigen challenge. J Appl Physiol Respir Environ Exerc Physiol 1983 0.77
66 Combination therapy in COPD: different response of COPD stages and predictivity of functional parameters. Eur Rev Med Pharmacol Sci 2005 0.76
67 Respiratory function at different altitudes. Respiration 1997 0.76
68 Emerging pathogens of community-acquired pneumonia: a two-year prospective study. J Chemother 1995 0.76
69 A new rheometer with special features designed for bronchial mucus analysis in clinical practice. Biorheology 1993 0.76
70 Clinical trial of the efficacy and safety of moguisteine in patients with cough associated with chronic respiratory diseases. Drugs Exp Clin Res 1993 0.76
71 Identification of subpopulations of bronchitic patients for suitable therapy by a dynamic rheological test. Int J Clin Pharmacol Res 1989 0.76
72 Failure to detect the presence of Chlamydia pneumoniae in sarcoid pathology specimens. Eur Respir J 1997 0.76
73 Pathology of bronchial asthma and animal models of asthma. Eur Respir J Suppl 1989 0.76
74 Influence of brodimoprim on polymorphonuclear leukocyte phagocytosis and oxidant radical production. Chemotherapy 1996 0.76
75 A method for maintaining, in vitro, TV-monitoring and counting ciliary beat frequency of samples from human ciliated respiratory epithelium brushing. Methods Find Exp Clin Pharmacol 1986 0.75
76 Chlamydia pneumoniae and asthma. Thorax 1998 0.75
77 Beclomethasone dipropionate versus budesonide inhalation suspension in children with mild to moderate persistent asthma. Eur Rev Med Pharmacol Sci 2002 0.75
78 The mechanism of action of doxofylline is unrelated to HDAC inhibition, PDE inhibition or adenosine receptor antagonism. Pulm Pharmacol Ther 2011 0.75
79 The influence of seaprose on erythromycin penetration into bronchial mucus in bronchopulmonary infections. Drugs Exp Clin Res 1992 0.75
80 [Ambroxol and mucociliary transport]. Arch Monaldi 1985 0.75
81 Effectiveness of beclomethasone dipropionate aerosolized through different nebulizers to asthmatic patients. Eur Rev Med Pharmacol Sci 2002 0.75
82 In vitro rheological assessment of mucolytic activity induced by seaprose. Pharmacol Res 1991 0.75
83 Nasal ciliary function and ultrastructure in Down syndrome. Laryngoscope 2001 0.75
84 A novel device for the prevention of airborne infections. J Clin Microbiol 1997 0.75
85 [Anatomico-radiological and functional correlations in the shock lung: role of the surfactant (proceedings)]. Radiol Med 1977 0.75
86 Outbreak of Chlamydia pneumoniae infection in former injection-drug users. Chest 1994 0.75
87 Mechanical behavior of isolated lungs in hyperlipemic animals. Respiration 1985 0.75
88 Evaluation of the elastic and viscous components of bronchial mucus before and after S-carboxymethylcysteine-Lys treatment. Int J Clin Pharmacol Res 1984 0.75
89 Nasal filters in prevention of seasonal rhinitis induced by allergenic pollen grains. Open clinical study. Eur Ann Allergy Clin Immunol 2012 0.75
90 Rheological profile of nesosteine: a new mucoactive agent. Int J Clin Pharmacol Res 1989 0.75
91 Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 1993 0.75
92 Increased frequency dependence of specific airway resistance in patients with laryngeal hemiplegia. Eur Respir J 2001 0.75
93 Topical tolerability of salmon calcitonin assessed by mucociliary transport velocity investigation. Arzneimittelforschung 1990 0.75
94 [Changes in the acid-base and water-electrolyte balance induced by salbutamol. "In vivo" studies in patients with chronic broncho-pulmonary disease and "in vitro" by tonometry of venous blood]. Minerva Med 1979 0.75
95 The effects of multiple dosing with zileuton on antigen-induced responses in sheep. Pulm Pharmacol Ther 1998 0.75
96 [Double-blind study of clinical and functional respiratory effects of dexamethasone isonicotinate aerosol]. Rev Inst Hyg Mines (Hasselt) 1973 0.75
97 [Preliminary results of a multicenter study of 1000 asthmatic patients treated with beclomethasone dipropionate (proceedings)]. Bull Int Union Tuberc 1979 0.75
98 Preliminary data on the action of nesosteine, a mucomodifying drug, on mucociliary transport. J Int Med Res 1987 0.75
99 Effect of atropine on ciliary beat in human upper respiratory tract epithelial cells. Int J Tissue React 1998 0.75
100 Chlamydia pneumoniae pneumonia: role of new macrolides. J Chemother 1995 0.75
101 [Comparative evaluation of the respiratory function and the acid-base equilibrium in patients with chronic bronchopulmonary disease after intravenous administration of 5 beta receptor agonists]. Minerva Med 1979 0.75
102 Rheological evaluation of mucus and its clinical implication. Eur J Respir Dis Suppl 1986 0.75
103 Rheological modifications of mucus in chronic bronchitic patients after treatment with stepronine-lysine salt. Drugs Exp Clin Res 1987 0.75
104 The role of chemotherapy in polymorphonuclear phagocytosis in pneumonia. J Chemother 1998 0.75
105 [Chronic obstructive lung disease evaluated functionally and radiologically (proceedings)]. Radiol Med 1977 0.75
106 Portable in vitro bath for an unsubmerged complete trachea. J Pharmacol Methods 1988 0.75
107 Biochemical and physiopathologic basis of non-specific bronchial reactivity. Panminerva Med 1983 0.75
108 Blood gas changes in nonasthmatic rhinitis during and after nonspecific airway challenge. Am Rev Respir Dis 1992 0.75
109 Atopy prevalence and spirometric performance in asymptomatic schoolchildren exposed to air pollution. Monaldi Arch Chest Dis 2001 0.75
110 Effects of sobrerol treatment on macromolecule secretion, ion and water fluxes in sheep trachea. Bull Eur Physiopathol Respir 1988 0.75
111 Age at symptom onset and distribution by sex and symptoms in patients sensitized to different allergens. Allergy 1998 0.75
112 Action of sobrerol on mucociliary transport. Respiration 1981 0.75
113 [Trimethoquinol by intravenous administration. II. Ventilatory and hemogasometric effects]. Clin Ter 1976 0.75
114 Effect of zafirlukast on methacholine and ultrasonically nebulized distilled water challenge in patients with mild asthma. Respiration 2003 0.75
115 Effect of Hygrobac filtro on viscosity and mucociliary transport of bronchial secretions. Minerva Anestesiol 1991 0.75
116 Antitussive activity and respiratory system effects of levodropropizine in man. Arzneimittelforschung 1988 0.75
117 Incidence of Chlamydia pneumoniae infection in vertically HIV-1 infected children. Eur J Clin Microbiol Infect Dis 1998 0.75
118 Pharmacokinetics of Sobrerol in chronic bronchitis. Comparison of serum and bronchial mucus levels. Eur J Clin Pharmacol 1983 0.75
119 The decay of thoracic gas volume during forced expiration. Respiration 1980 0.75
120 [Non-allergic factors of bronchial asthma]. Recenti Prog Med 1989 0.75
121 In vitro antibiotic activity against Chlamydia pneumoniae clinical isolates. J Chemother 2003 0.75
122 [Sub-MIC concentrations of rokitamycin inhibit S. aureus' adhesiveness to human epithelial cells]. G Ital Chemioter 1995 0.75
123 Thymomodulin increases HLA-DR expression by macrophages but not T-lymphocyte proliferation in autologous mixed leucocyte reaction. Eur Respir J 1993 0.75
124 Review on sobrerol as a muco-modifying drug: experimental data and clinical findings in hypersecretory bronchopulmonary diseases. Int J Clin Pharmacol Res 1987 0.75
125 Effects of salbutamol and bitolterol mesilate on pO2 levels in asthmatic patients and healthy volunteers. Arzneimittelforschung 1992 0.75
126 Community-acquired pneumonia: role of atypical organisms. Monaldi Arch Chest Dis 2001 0.75
127 Thymomodulin increases release of granulocyte-macrophage colony stimulating factor and of tumour necrosis factor in vitro. Eur Respir J 1992 0.75
128 [Prospects of research on the behavior of endoalvlar surface tension ar aerosol administration of pharmacological substances]. Minerva Med 1967 0.75
129 Critical evaluation of guidelines for the treatment of lower respiratory tract bacterial infections. Respir Med 2001 0.75
130 [Clinico-radiological and functional aspects of respiratory syndromes caused by collagen diseases]. Minerva Med 1976 0.75
131 Response to acetylcholine and myosin content of isolated canine airways. J Appl Physiol (1985) 1989 0.75